価格表

在庫・価格 : 2024年05月18日 10時54分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Anti-Human CD34 Allophycocyanin MAb (Clone QBEnd10)
データシート※最新のデータシートでない場合があります
FAB7227A RSDアールアンドディー システムス
R&D Systems, Inc.
100 tests ¥96,000
(未発注)
追加

在庫・価格 : 2024年05月18日 10時54分 現在

Anti-Human CD34 Allophycocyanin MAb (Clone QBEnd10)

  • 商品コード:FAB7227A
  • メーカー:RSD
  • 包装:100tests
  • 価格: ¥96,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Capsomidis A et al. Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation. Mol. Ther. 2018 Feb;26(2):354-365
Capsomidis A et al
2018/01/01
Species: Human, Applications: Flow PubMed
2 Collinson-Pautz MR et al. Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies. Leukemia 2019 Feb;
Collinson-Pautz MR et al
2019/01/01
PubMed
3 Valton J et al. A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies. Sci Rep 2018 Jun;8(1):8972
Valton J et al
2018/01/01
PubMed
4 Sachdeva M et al. Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality. Nat Commun 2019 11;10(1):5100
Sachdeva M et al
2019/01/01
PubMed
5 Mosti L et al. Targeted multi-epitope switching enables straightforward positive/negative selection of CAR T cells. Gene Ther 2021 Feb;
Mosti L et al
2021/01/01
Species: Human, Applications: Flow Cytometry PubMed
  • No.: 1
  • 文献情報:
    Capsomidis A et al. Chimeric Antigen Receptor-Engineered Human Gamma Delta T Cells: Enhanced Cytotoxicity with Retention of Cross Presentation. Mol. Ther. 2018 Feb;26(2):354-365
    Capsomidis A et al
    2018/01/01
  • 備考:
    Species: Human, Applications: Flow
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Collinson-Pautz MR et al. Constitutively active MyD88/CD40 costimulation enhances expansion and efficacy of chimeric antigen receptor T cells targeting hematological malignancies. Leukemia 2019 Feb;
    Collinson-Pautz MR et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Valton J et al. A Versatile Safeguard for Chimeric Antigen Receptor T-Cell Immunotherapies. Sci Rep 2018 Jun;8(1):8972
    Valton J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Sachdeva M et al. Repurposing endogenous immune pathways to tailor and control chimeric antigen receptor T cell functionality. Nat Commun 2019 11;10(1):5100
    Sachdeva M et al
    2019/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Mosti L et al. Targeted multi-epitope switching enables straightforward positive/negative selection of CAR T cells. Gene Ther 2021 Feb;
    Mosti L et al
    2021/01/01
  • 備考:
    Species: Human, Applications: Flow Cytometry
  • 参照:
    PubMed